About Ambion
Ambion is a Healthcare company based in Austin (United States) founded in 1988. It operates as a RNA extraction reagents and kits are supplied for molecular research. Ambion has raised $10.5 million across 6 funding rounds from investors including HHS and Telegraph Hill Partners. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics. Its competitors include GenScript, Parse Biosciences, Biofidelity, Sino Biological and RareCyte and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Ambion was founded in 1988 in Austin, United States, within the biotechnology sector. RNA extraction kits, isolation reagents, and single cell-to-CT solutions for qRT-PCR are developed and distributed. DNA and RNA purification equipment is also offered, supporting laboratory analysis needs. Operations focus on tools for nucleic acid handling, with products utilized in research settings across the United States and internationally.
- Headquarters Austin, United States
- SectorsHealthcare
- Website ambion.com
- Social LinkedIn
- Total Equity Funding$10.5M (USD)
in 6 rounds
- Latest Funding Round$1.17M (USD), Grant
Mar 2010
- InvestorsHHS
& 1 more
Funding Insights of Ambion
Ambion has successfully raised a total of $10.5M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.17 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.5M
- Total Rounds 6
- Last Round Grant — $1.17M
- First Round $10.5M
(May 2003)
- Investors Count 2
All 6 funding rounds of Ambion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Ambion
Ambion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science, medical device and healthcare companies | – | thpartners.net | San Francisco, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Ambion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ambion
1 people are tracked at Ambion (1 in team).
| Name | Role | Group |
|---|---|---|
Nicola Parsons | Technical Support Manager RNA | Team |
Complete people profiles for Ambion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ambion
3 dated milestones of Ambion across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Ambion is founded.
- Funding First funding round of $10.5M.
- Funding Latest funding round, Grant, of $1.2M.
Competitors of Ambion
Ambion has 8 listed competitors in our database, 6 of them funded. They include GenScript, Parse Biosciences, Biofidelity, Sino Biological and RareCyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application |
Detailed competitors of Ambion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ambion
Websites that share an audience with Ambion (ambion.com).
Websites whose visitors overlap most with Ambion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| appliedbiosystems.com | 100% | – | – | View details | |
| invitrogen.com | 100% | 5.2K | #3,688,642 | View details | |
| asuragen.com | 100% | 8.4K | #2,708,489 | View details | |
promega.com | promega.com | 99% | – | #192,389 | – |
| clontech.com | 90% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Ambion
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Ambion (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ambion
Complete news archive for Ambion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambion
Ambion was founded in 1988 and raised its 1st funding round 15 years after it was founded.
Ambion is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Ambion is a funded company, having raised a total of $10.5M across 6 funding rounds to date. The company's 1st funding round was a Private Equity Round of $10.5M, raised on May 2003.
Ambion was founded in 1988 in Austin, United States, within the biotechnology sector. RNA extraction kits, isolation reagents, and single cell-to-CT solutions for qRT-PCR are developed and distributed. DNA and RNA purification equipment is also offered, supporting laboratory analysis needs. Operations focus on tools for nucleic acid handling, with products utilized in research settings across the United States and internationally.
Ambion's top competitors include Sino Biological, Qiagen and Parse Biosciences.
Ambion has 2 investors. Key investors include HHS, and Telegraph Hill Partners.